176 related articles for article (PubMed ID: 8943788)
1. Oestrogen formation in breast: clinical and biological importance.
Dowsett M; Detre S; Rowlands M; Grimshaw R
J Endocrinol; 1996 Sep; 150 Suppl():S59-63. PubMed ID: 8943788
[TBL] [Abstract][Full Text] [Related]
2. Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.
Sonne-Hansen K; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):25-34. PubMed ID: 15748829
[TBL] [Abstract][Full Text] [Related]
3. Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole.
Macedo LF; Guo Z; Tilghman SL; Sabnis GJ; Qiu Y; Brodie A
Cancer Res; 2006 Aug; 66(15):7775-82. PubMed ID: 16885381
[TBL] [Abstract][Full Text] [Related]
4. The control and biological importance of intratumoural aromatase in breast cancer.
Dowsett M; Lee K; Macaulay VM; Detre S; Rowlands M; Grimshaw R
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):145-50. PubMed ID: 8603035
[TBL] [Abstract][Full Text] [Related]
5. An in vivo model of intratumoural aromatase using aromatase-transfected MCF7 human breast cancer cells.
Lee K; Macaulay VM; Nicholls JE; Detre S; Ashworth A; Dowsett M
Int J Cancer; 1995 Jul; 62(3):297-302. PubMed ID: 7628871
[TBL] [Abstract][Full Text] [Related]
6. Effects of novel retinoic acid metabolism blocking agent (VN/14-1) on letrozole-insensitive breast cancer cells.
Belosay A; Brodie AM; Njar VC
Cancer Res; 2006 Dec; 66(23):11485-93. PubMed ID: 17145897
[TBL] [Abstract][Full Text] [Related]
7. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
Miller WR; Stuart M; Sahmoud T; Dixon JM
Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
[TBL] [Abstract][Full Text] [Related]
8. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
9. Aromatase and the breast: regulation and clinical aspects.
Miller WR
Maturitas; 2006 Jul; 54(4):335-41. PubMed ID: 16730141
[TBL] [Abstract][Full Text] [Related]
10. Steroid metabolism in breast cancer.
Foster PA
Minerva Endocrinol; 2008 Mar; 33(1):27-37. PubMed ID: 18277377
[TBL] [Abstract][Full Text] [Related]
11. Regulation of aromatase and sulphatase in breast tumour cells.
Purohit A; Wang DY; Ghilchik MW; Reed MJ
J Endocrinol; 1996 Sep; 150 Suppl():S65-71. PubMed ID: 8943789
[TBL] [Abstract][Full Text] [Related]
12. Biology of aromatase inhibitors: pharmacology/endocrinology within the breast.
Miller WR
Endocr Relat Cancer; 1999 Jun; 6(2):187-95. PubMed ID: 10731108
[TBL] [Abstract][Full Text] [Related]
13. Tumor-stromal interaction through the estrogen-signaling pathway in human breast cancer.
Yamaguchi Y; Takei H; Suemasu K; Kobayashi Y; Kurosumi M; Harada N; Hayashi S
Cancer Res; 2005 Jun; 65(11):4653-62. PubMed ID: 15930283
[TBL] [Abstract][Full Text] [Related]
14. Aromatase expression increases the survival and malignancy of estrogen receptor positive breast cancer cells.
Mukhopadhyay KD; Liu Z; Bandyopadhyay A; Kirma NB; Tekmal RR; Wang S; Sun LZ
PLoS One; 2015; 10(4):e0121136. PubMed ID: 25837259
[TBL] [Abstract][Full Text] [Related]
15. Aromatase in human breast carcinoma.
Perel E; Blackstein ME; Killinger DW
Cancer Res; 1982 Aug; 42(8 Suppl):3369s-3372s. PubMed ID: 7083202
[TBL] [Abstract][Full Text] [Related]
16. Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer.
Boulay A; Rudloff J; Ye J; Zumstein-Mecker S; O'Reilly T; Evans DB; Chen S; Lane HA
Clin Cancer Res; 2005 Jul; 11(14):5319-28. PubMed ID: 16033851
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibitors: new endocrine treatment of breast cancer.
Brueggemeier RW
Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
[TBL] [Abstract][Full Text] [Related]
18. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors and breast cancer.
Miller WR
Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
[TBL] [Abstract][Full Text] [Related]
20. Effects of the antiestrogen tamoxifen and the aromatase inhibitor letrozole on serum hormones and bone characteristics in a preclinical tumor model for breast cancer.
Núñez NP; Jelovac D; Macedo L; Berrigan D; Perkins SN; Hursting SD; Barrett JC; Brodie A
Clin Cancer Res; 2004 Aug; 10(16):5375-80. PubMed ID: 15328175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]